Nombre de la Acción | Símbolo de la Acción | Bolsa de Valores | Tipo de Valor |
---|---|---|---|
Neurogene Inc | NGNE | NASDAQ | Acción Común |
Precio de Apertura | Precio Mínimo | Precio Máximo | Precio de cierre | Precio Anterior |
---|---|---|---|---|
37.35 |
Noticias Recientes
Fecha | Hora | Fuente | Noticia |
---|---|---|---|
05/6/2024 | 06:30 | BW | Neurogene to Participate in Upcoming Conferences |
03/6/2024 | 06:30 | BW | Neurogene Announces NGN-401 Gene Therapy for Rett Syndrome.. |
10/5/2024 | 06:30 | BW | Neurogene Reports First Quarter 2024 Financial Results and.. |
07/5/2024 | 05:19 | BW | Neurogene Presents Favorable Safety Data from Phase 1/2.. |
22/4/2024 | 15:36 | BW | Neurogene Announces Upcoming Presentation of Safety Data.. |
18/3/2024 | 15:14 | BW | Neurogene Reports Fourth Quarter and Full Year 2023.. |
04/3/2024 | 06:30 | BW | Neurogene Announces Expansion and Plans for More Rapid.. |
29/2/2024 | 06:30 | BW | Neurogene to Participate in Upcoming Investor Conferences |
16/1/2024 | 06:00 | BW | Neurogene Announces Appointment of Julie Jordan, M.D., as.. |
05/1/2024 | 06:00 | BW | Neurogene Announces Business Update and 2024 Outlook |